Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 10;12(3):e058751.
doi: 10.1136/bmjopen-2021-058751.

Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study

Tessa Runels  1 , Elizabeth J Ragan  1 , Alicia S Ventura  2   3 , Michael R Winter  4 , Laura F White  5 , C Robert Horsburgh  1   5   6 , Jeffrey H Samet  2   3 , Richard Saitz  2   3 , Karen R Jacobson  7
Affiliations

Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study

Tessa Runels et al. BMJ Open. .

Abstract

Objective: To quantify the proportion of people living with HIV (PLWH) with other tuberculosis (TB) risk factors that completed the latent tuberculosis infection (LTBI) care cascade and describe factors associated with attrition. The care cascade was defined as follows: (1) receipt of an LTBI test and result, (2) initiation of LTBI treatment and (3) completion of LTBI treatment.

Design: Prospective cohort study.

Setting: Reactivation of LTBI remains a large source of active TB disease in the USA. PLWH and those who use substances are at greater risk and are harder to engage and retain in care.

Participants: Participants enrolled in a Boston cohort of PLWH from 2012 to 2014.

Primary and secondary outcome measures: Our primary outcome was the number and proportion of participants who completed each stage of the cascade and the factors associated with completing each stage. Our secondary outcomes were differences between participants tested with an interferon gamma release assay (IGRA) versus tuberculin skin test and differences between participants who tested positive versus negative for LTBI.

Results: Only 189 of 219 (86.3%) participants completed testing. Five of the 11 with LTBI initiated and three completed treatment. Participants tested with an IGRA were more likely to complete testing (OR 3.87, 95% CI 1.05 to 14.30) while among participants successfully tested, being foreign-born was associated with a positive test result (OR 3.95; 95% CI 1.13 to 13.77).

Conclusions: Although the majority completed LTBI testing, our findings warrant further investigation in a larger cohort to better understand factors that lead to suboptimal treatment initiation and completion in a low-burden country.

Keywords: HIV & AIDS; substance misuse; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: RS reports that Alkermes provides medication for a comparative effectiveness study funded by NIAAA/NIH for which he is the principal investigator. Authors report no other conflicts.

Figures

Figure 1
Figure 1
Flowchart of the latent tuberculosis infection (LTBI) cascade of care: (1) completion of tuberculosis (TB) testing; (2) initiation of TB preventive therapy; and (3) completion of TB preventive therapy.
Figure 2
Figure 2
Flowchart of study participants who were eligible for TB testing, received a test (IGRA or TST), were successfully tested (ie, received a valid result), tested positive for TB infection, initiated treatment and completed treatment (N=250). ARCH, Alcohol Research Collaboration on HIV; IGRA, interferon-gamma release assay; LTBI, latent TB infection; TB, tuberculosis; TST, tuberculin skin test.
See this image and copyright information in PMC

References

    1. Sterling TR, Njie G, Zenner D, et al. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep 2020;69:1–11. 10.15585/mmwr.rr6901a1 - DOI - PMC - PubMed
    1. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 2017;64:111–5. 10.1093/cid/ciw778 - DOI - PMC - PubMed
    1. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010;1:CD000171. 10.1002/14651858.CD000171.pub3 - DOI - PMC - PubMed
    1. Kwan CK, Ernst JD. Hiv and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011;24:351–76. 10.1128/CMR.00042-10 - DOI - PMC - PubMed
    1. Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis 2009;48:72–82. 10.1086/594126 - DOI - PMC - PubMed

Publication types

MeSH terms